Dipeptide-catalysed Michael reaction under physiological conditions: Examination of potential bioorthogonality
Florian Schuster,Benedikt W. Grau,Hong-Gui Xu,Andriy Mokhir,Svetlana B. Tsogoeva
DOI: https://doi.org/10.1016/j.bmc.2024.117650
IF: 3.461
2024-02-24
Bioorganic & Medicinal Chemistry
Abstract:Reactions for drug synthesis under cell-like conditions or even inside living cells can potentially be used e.g. , to minimize toxic side effects, to maximize bioactive compound efficacy and/or to address drug delivery problems. Those reactions should be biorthogonal to enable the generation of drug-like compounds with sufficiently good yields. In the known bioorthogonal Michael reactions, the use of thiols and phosphines as nucleophiles ( e.g. , in CS and CP bond formation reactions) is very common. No bioorthogonal Michael addition with a carbon nucleophile is known yet. Therefore, the development of such a reaction might be interesting for future drug discovery research. In this work, the metal-free Michael addition between cyclohexanone and various trans-β- nitrostyrenes (CC bond formation reaction), catalysed by a dipeptide salt H-Pro-Phe-O - Na + , was investigated for the first time in the presence of glutathione (GSH) and in phosphate-buffered saline (PBS). We demonstrated that with electron-withdrawing substituents on the aromatic ring and in β -position of the trans-β- nitrostyrene yields up to 64% can be obtained under physiological conditions, indicating a potential bioorthogonality of the studied Michael reaction. In addition, the selected Michael products demonstrated activity against human ovarian cancer cells A2780. This study opens up a new vista for forming bioactive compounds via CC bond formation Michael reactions under physiological (cell-like) conditions.
biochemistry & molecular biology,chemistry, medicinal, organic